| Term es nes pval sidak fdr geneset_size leading_edge leading_edge_size |
| Cholesterol metabolism with bloch and kandutschrussell pathways 0.6961057799924111 2.8420337509314355 0.0044826745726065 0.9318923425046156 0.5244764008623791 24 P04035,Q9UBM7,Q14739,Q16850,P35610,P48449,P37268,Q15392,Q15800 9 |
| Sphingolipid metabolism in senescence 0.8549044193329376 2.684858800962077 0.0072560453404431 0.98715671394501 0.5244764008623791 12 P16278,P04062,Q06136,Q13510 4 |
| Familial partial lipodystrophy fpld 0.8923501457378616 2.578481211204832 0.0099235696231136 0.9974302215413992 0.5244764008623791 8 O75844,P49354 2 |
| Glycosaminoglycan degradation 0.8951942766671197 2.4741521305890206 0.0133552813207735 0.9996777775996544 0.5244764008623791 6 P16278,P08236,P15586,P54802 4 |
| Acquired partial lipodystrophy barraquersimons syndrome 0.9523453157568617 2.4450555869461477 0.0144829817963318 0.9998373894689252 0.5244764008623791 5 P49354 1 |
| Sphingolipid metabolism integrated pathway 0.8470539975377512 2.4444580964980935 0.0145069932033767 0.99983974153018 0.5244764008623791 9 Q96G23,Q06136,Q9NRA0,P27544,O95470,O15269,Q13510 7 |
| Sphingolipid metabolism overview 0.8470539975377512 2.4444580964980935 0.0145069932033767 0.99983974153018 0.5244764008623791 9 Q96G23,Q06136,Q9NRA0,P27544,O95470,O15269,Q13510 7 |
| Cholesterol biosynthesis with skeletal dysplasias 0.8797487729834493 2.4102506505060113 0.015941564204513 0.9999329356960124 0.5244764008623791 6 Q9UBM7,Q15392,Q14739,Q16850 4 |
| Degradation pathway of sphingolipids including diseases 0.8531440671353814 2.3530461031167524 0.018620325284204 0.9999868610294416 0.5244764008623791 7 P06865,P06280,P16278,O43681 4 |
| Sphingolipid pathway 0.81232844874571 2.3517677537778563 0.0186844368462804 0.9999873644375962 0.5244764008623791 10 P04062,Q96G23,Q06136,Q9NRA0,O95470,O15269,Q13510 7 |
| Electron transport chain oxphos system in mitochondria 0.5150539401907646 2.3255110322390884 0.0200446506967497 0.9999944873529067 0.5244764008623791 46 P06576,P12235,O75880,P12236,P56385,O43676,O95168,O14949,P00403,P21912,O75306,P22695,P14406,O75964,O96000,P24539,Q9Y6M9,Q9UDW1 18 |
| Progeriaassociated lipodystrophy 0.7699361282762403 2.2188320831009367 0.0264981504447117 0.9999998939782372 0.5244764008623791 11 O75844,P49354,O60725 3 |
| Ferroptosis 0.5950725130990607 2.2027299434550955 0.0276137884695244 0.9999999465930768 0.5244764008623791 24 P04035,P37268,P09601,Q9Y277,P45880,Q9NZZ3 6 |
| Statin inhibition of cholesterol production 0.8769853628153056 2.1462920381387547 0.0318496864221398 0.9999999960754606 0.5244764008623791 5 P04035,P35610,Q8WTV0,P37268 4 |
| Influence of laminopathies on wnt signaling 0.7377598793516789 2.1290384098062147 0.0332510826945378 0.9999999983496 0.5244764008623791 12 O75844,P49354 2 |
| Overlap between signal transduction pathways contributing to lmna laminopathies 0.6646337375853407 2.118720660828509 0.0341140812117344 0.999999999032504 0.5244764008623791 17 O75844,P55209,P49354,O60725 4 |
| Striated muscle contraction pathway 0.7855504776467823 2.009643751139898 0.0444689071898565 0.999999999998464 0.5865185702690751 6 P28289 1 |
| Oxidation by cytochrome p450 0.7709025467466528 1.9456755922522435 0.0516937203446894 0.9999999999999836 0.5865185702690751 6 O43169,Q16850 2 |
| Mecp2 and associated rett syndrome 0.557932528848236 1.9332171838420495 0.0532094487653069 0.9999999999999936 0.5865185702690751 22 Q00013,P52597,Q03518,P35637,P31943 5 |
| Metabolism of spingolipids in er and golgi apparatus 0.8237358382106397 1.9291791498606723 0.053708625662447 0.9999999999999954 0.5865185702690751 5 O95470,Q06136,Q9NRA0 3 |
| Proteoglycan biosynthesis 0.765883858507081 1.9236573698579988 0.0543975448586013 0.999999999999997 0.5865185702690751 6 Q8TB61,Q93063,Q8NCH0,Q96L58 4 |
| Nad biosynthetic pathways 0.8209783331220531 1.9178051895771655 0.0551357175000712 0.999999999999998 0.5865185702690751 5 P43490 1 |
| Ketogenesis and ketolysis 0.7621997724566352 1.9074617293923073 0.0564608223329423 0.9999999999999992 0.5865185702690751 6 O43772,P35610,P23786 3 |
| Cholesterol biosynthesis pathway 0.675695330558269 1.882053018651411 0.0598288173685845 1.0 0.5865185702690751 13 Q9UBM7,Q16850,P48449,P37268,Q15800 5 |
| S1p receptor signal transduction 0.7174950597541967 1.8530116123549265 0.0638806942573821 1.0 0.5968841459039969 9 Q13510 1 |
| Nonalcoholic fatty liver disease 0.456353459312068 1.8453380238748656 0.0649883825170301 1.0 0.5968841459039969 52 P13073,O96000,O00459,P54646,P31751,O43676,P14406,P60953,Q9P0J0,Q96J02,Q9Y478,O95168,P00403,O75306,P47985,Q86Y39,P22695,Q9Y6M9,Q9UDW1,O14949,P21912 21 |
| Nad metabolism 0.8549535446386007 1.824595560455759 0.0680620838734258 1.0 0.5968841459039969 4 P43490 1 |
| 7oxoc and 7betahc pathways 0.6935885390859179 1.7924228611540218 0.073065255484807 1.0 0.5968841459039969 10 Q15125,Q9UBM7,P61916 3 |
| Vitamin d metabolism 0.9309056956115744 1.7548991806021503 0.0792765543645015 1.0 0.5968841459039969 3 P04062,Q9UBM7 2 |
| Omega3 omega6 fatty acid synthesis 0.7266541269478519 1.7498110831361655 0.080150917597622 1.0 0.5968841459039969 6 O15254,Q15067 2 |
| Tryptophan metabolism 0.6227899835167763 1.733206105640718 0.0830590422054162 1.0 0.5968841459039969 15 P51648,P05091,Q16836,P35610,Q15392 5 |
| Vitamin a and carotenoid metabolism 0.7534895663031624 1.6357249596083785 0.1018971632681351 1.0 0.6412213339244704 5 Q8WTV0 1 |
| Mitochondrial long chain fatty acid betaoxidation 0.6277444013593206 1.6307715062238382 0.1029385419009183 1.0 0.6412213339244704 13 O43772,Q16836,P40939,P23786 4 |
| Mitochondrial complex iii assembly 0.6433707948912715 1.5455240564053354 0.1222195546839797 1.0 0.6455162366274797 10 O14949,Q6DKK2,Q9UDW1 3 |
| Triacylglyceride synthesis 0.7161366222894424 1.4769218582332209 0.1396965849289131 1.0 0.6757013584689714 5 Q9NUQ2,Q9HCL2 2 |
| Copper homeostasis 0.6466007326913614 1.4675487783032877 0.1422268302128939 1.0 0.6804131557384847 8 O75880,P35670 2 |
| Immune response to tuberculosis 0.7107913531526704 1.4540724600068595 0.1459262179901816 1.0 0.6906574487178174 5 Q03518 1 |
| Mitochondrial complex iv assembly 0.6167204736366622 1.4123482200407018 0.1578474547681474 1.0 0.6940645437599424 10 P14406 1 |
| Ethanol effects on histone modifications 0.5903038079059243 1.3760362401566824 0.1688104136533341 1.0 0.705934457095761 12 P05091,P00374,P41440 3 |
| Glycerolipids and glycerophospholipids 0.686735358539483 1.3509403144866283 0.176714552748892 1.0 0.7239981754398104 5 Q9HCL2 1 |
| Interactions between loxl4 and oxidative stress pathway 0.7325653798256528 1.338262751702808 0.1808107995395564 1.0 0.7256701887560723 4 Q8TAG9,Q96EB6,Q16543 3 |
| Inclusion body myositis 0.8094262389783724 1.2980606109404291 0.1942665081272094 1.0 0.7319919183196733 3 Q92542 1 |
| Sarscov2 and covid19 pathway 0.8062867900875206 1.2862286505759857 0.1983632748382642 1.0 0.7319919183196733 3 Q8WTV0 1 |
| Fatty acid betaoxidation 0.4960505002576226 1.2610829121655374 0.2072789764602669 1.0 0.7471971719110976 19 O43772,Q16836,P35610,P23786 4 |
| Glycerophospholipid biosynthetic pathway 0.6030635797324844 1.2581958633959187 0.2083209306211197 1.0 0.7471971719110976 8 Q9BTU6,Q9Y6K0,Q9HCL2,O00116 4 |
| 1q211 copy number variation syndrome 0.5846178924564164 1.250359670897594 0.2111681897462207 1.0 0.7471971719110976 10 P54646,Q9NPH0 2 |
| Kennedy pathway from sphingolipids 0.6626435846415075 1.2473049794951403 0.2122856923195808 1.0 0.7471971719110976 5 O95470,Q9UG56,P35790 3 |
| Intracellular trafficking proteins involved in cmt neuropathy 0.5834612055674244 1.2444977115969988 0.2133164410690908 1.0 0.7471971719110976 10 O60333,Q9NR77,Q9UI14 3 |
| Il18 signaling pathway 0.3956304110190834 1.2195637527305716 0.2226302942767204 1.0 0.7479377302105551 54 Q9NZJ7,Q92733,P40939,Q13011,O96008,Q9UMR5,Q9NQX7,Q16836,Q8TCT8,Q9Y6M7,Q9HC07,P09601 12 |
| Metapathway biotransformation phase i and ii 0.4506017395763119 1.1928632067792202 0.232922950923484 1.0 0.7611362002854832 23 Q16850,Q8NCH0,Q6UW02,Q7LGA3,P21964,Q9NRB3 6 |
| Adipogenesis 0.5149115183406919 1.1781476181368071 0.238737761134586 1.0 0.7717036819377429 16 O75844,P43490,P14174 3 |
| 15q112 copy number variation syndrome 0.6855541718555405 1.1496204818692095 0.2503002184821441 1.0 0.7810276973404605 4 Q96CW5,Q7L576,Q9BSJ2 3 |
| Sterol regulatory elementbinding proteins srebp signaling 0.4285054876425541 1.1462246620090264 0.2517022060298577 1.0 0.7810276973404605 34 Q9HCL2,Q16850,Q8WTV0,P48449,P37268 5 |
| Oxysterols derived from cholesterol 0.5794796966928865 1.1439870009137392 0.2526290279791183 1.0 0.7810276973404605 8 Q9UBM7 1 |
| Melatonin metabolism and effects 0.762527233115446 1.1219135124732835 0.2618992147965069 1.0 0.790988537617733 3 P49841,P42892 2 |
| Urea cycle and related diseases 0.8948350964530198 1.1039286262157124 0.2696241000003785 1.0 0.799831526577514 2 Q9Y619 1 |
| Irinotecan pathway 0.8851897946484151 1.068003009140657 0.2855191544251245 1.0 0.8008900204503835 2 O15118 1 |
| Cytosine methylation 0.6183668199328742 1.0567537862193537 0.2906239706316609 1.0 0.8008900204503835 5 P48735 1 |
| Oxidative stress response 0.6118370896437637 1.0287358859527196 0.3036038018392599 1.0 0.8252503340903521 5 P09601 1 |
| Mthfr deficiency 0.558385829938024 0.9786202621237649 0.3277676438999224 1.0 0.8580519507926714 6 P21964 1 |
| Mitochondrial complex i assembly model oxphos system 0.4180281790742342 0.962050784279878 0.3360240944828536 1.0 0.8580519507926714 25 Q96CU9,O43676,O95168,O75306,Q9P0J0,O96000,Q9Y6M9 7 |
| Regulation of wnt bcatenin signaling by small molecule compounds 0.7188033459786557 0.959957396101168 0.3370766574322621 1.0 0.8580519507926714 3 P48729 1 |
| Nodlike receptor nlr signaling pathway 0.7055711173358219 0.9116713749477232 0.3619417369946229 1.0 0.877186135275606 3 Q96RT1,O15111 2 |
| Nad metabolism in oncogeneinduced senescence and mitochondrial dysfunctionassociated senescence 0.4852931625205348 0.9000886491958262 0.3680730760886521 1.0 0.8804307980040559 14 P43490 1 |
| Vitamin dsensitive calcium signaling in depression 0.5330236505052244 0.8889488214024608 0.3740305854785368 1.0 0.884527389802449 7 Q8NB78,P00390 2 |
| Nephrotic syndrome 0.4900560808531423 0.8820808115974543 0.3777331079953088 1.0 0.884527389802449 13 Q14108 1 |
| Mitochondrial immune response to sarscov2 0.5071456861127384 0.8240405070293382 0.409916542194694 1.0 0.8890388932693638 9 Q9Y276,Q7Z434,Q9Y375,Q9Y6M9,Q9BQ95 5 |
| Alzheimers disease and mirna effects 0.4013088877549775 0.8223914072344435 0.4108541682370195 1.0 0.8890388932693638 86 P14735,P12235,P28074,O95197,Q9NQC3,Q92542,P05067,P49721,Q96IX5,P21796,Q9UJX6,P28070,P20618,Q9Y277,P28072,P45880 16 |
| Alzheimers disease 0.3997388543064966 0.8201286821968369 0.4121427528324721 1.0 0.8890388932693638 85 P14735,P12235,P28074,O95197,Q9NQC3,Q92542,P05067,P49721,P21796,Q9UJX6,Q9Y277,P28072,P45880 13 |
| Allograft rejection 0.4911717731887794 0.8099238424713142 0.4179839477032729 1.0 0.8890388932693638 11 Q9BY49,P08183,P10321,P08670 4 |
| Vitamin b12 metabolism 0.516418366909475 0.7861100599638395 0.431803011158993 1.0 0.8890388932693638 6 Q8WTV0 1 |
| Neuroinflammation 0.5530573113633125 0.7796459115760364 0.4355993239597384 1.0 0.8890388932693638 5 P00403,Q8N9N2,O15111 3 |
| Fluoroacetic acid toxicity 0.5308420087264981 0.6880386101952041 0.4914284676740768 1.0 0.9730934558579402 5 P05091 1 |
| Pkcgamma calcium signaling pathway in ataxia 0.7663347853142541 0.6480776799273849 0.5169347094341283 1.0 0.9872772832604744 2 P23634 1 |
| Nanomaterial induced apoptosis 0.480989287989764 0.6477253683134453 0.517162593382894 1.0 0.9872772832604744 7 O95831 1 |
| Folate metabolism 0.4467612602935887 0.6466797222231597 0.5178392495692781 1.0 0.9872772832604744 13 Q8WTV0,P00374 2 |
| Mevalonate arm of cholesterol biosynthesis pathway 0.4562431100235746 0.6311049537485249 0.5279719023261547 1.0 0.9872772832604744 11 P35610,P37268 2 |
| Canonical and noncanonical notch signaling 0.759489732420666 0.625795556199835 0.531449046954954 1.0 0.9872772832604744 2 P55081 1 |
| Glutathione metabolism 0.4786783455149914 0.6173549602461132 0.5370006229009796 1.0 0.9879285548005686 6 O75874 1 |
| P53 transcriptional gene network 0.4676493332803278 0.6085391113035054 0.5428299741094351 1.0 0.9879285548005686 8 P04066,Q709F0 2 |
| Vitamin d receptor pathway 0.4315687460849808 0.6001043286658003 0.5484367079199488 1.0 0.9879285548005686 14 Q96KA5,P08183,P49427,Q5VV42 4 |
| Oxidative phosphorylation 0.3688562259730948 0.5991676477123705 0.5490610944970236 1.0 0.9879285548005686 27 P06576,O95168,O75306,Q86Y39,O96000,O75964,P24539,Q9Y6M9 8 |
| Nanoparticle triggered autophagic cell death 0.5401618929016171 0.5888731853525784 0.5559463468071673 1.0 0.9948945473966648 4 P49815,Q13111,Q9NT62 3 |
| Nuclear receptors in lipid metabolism and toxicity 0.7339763534536493 0.5453516616879177 0.5855116791715804 1.0 0.9963847483717032 2 P08183 1 |
| Ccl18 signaling pathway 0.4466179886717382 0.5330712988363914 0.5939842259942596 1.0 0.9963847483717032 9 P08670,Q86UE4 2 |
| Development of ureteric collection system 0.5199252801992509 0.517909671083456 0.604521294091521 1.0 1.0 4 Q12948,P35222,O94813 3 |
| Omega9 fatty acid synthesis 0.4420560747663448 0.460987302412756 0.6448077150145972 1.0 1.0 6 O95573,P49327,O95864,O00767,P33121 5 |
| Canonical nfkb pathway 0.7053515868077163 0.460656992715705 0.6450447151726943 1.0 1.0 2 O15111 1 |
| Sting pathway in kawasakilike disease and covid19 0.7053515868077163 0.460656992715705 0.6450447151726943 1.0 1.0 2 O15111 1 |
| Altered glycosylation of muc1 in tumor microenvironment 0.7053515868077163 0.460656992715705 0.6450447151726943 1.0 1.0 2 O15111 1 |
| Photodynamic therapyinduced nfkb survival signaling 0.7053515868077163 0.460656992715705 0.6450447151726943 1.0 1.0 2 O15111 1 |
| Autophagy 0.4249294671263069 0.4340102412451382 0.664281004170949 1.0 1.0 9 P42345,Q9Y478,P54646 3 |
| Exrna mechanism of action and biogenesis 0.5558667911609088 0.4173401283725078 0.6764296408119375 1.0 1.0 3 Q9HAV4,Q8WYQ5 2 |
| Hostpathogen interaction of human coronaviruses autophagy 0.5552443199502043 0.4155931210116245 0.6777077612130458 1.0 1.0 3 P42345,Q99570 2 |
| Serotonin and anxiety 0.6851275668948384 0.4048819643966678 0.6855642762086716 1.0 1.0 2 Q08209 1 |
| Aryl hydrocarbon receptor pathway wp2873 0.4460940565694859 0.3655103328434868 0.7147304951071223 1.0 1.0 5 P12931,Q16543 2 |
| Supression of hmgb1 mediated inflammation by thbd 0.5367664046798687 0.365371004556498 0.714834482340009 1.0 1.0 3 O15111 1 |
| Congenital generalized lipodystrophy cgl 0.6670815183571924 0.3582695626493076 0.7201415938277762 1.0 1.0 2 P31751 1 |
| Rala downstream regulated genes 0.443475552787296 0.3565264500140206 0.7214463474861381 1.0 1.0 5 P11233,P60953,Q96KP1,Q8IYI6 4 |
| Ectoderm differentiation 0.3478834274876362 0.3485539527560403 0.7274242024822666 1.0 1.0 20 P16278 1 |
| Tyrobp causal network in microglia 0.435456668758172 0.3294895662905936 0.7417856789881854 1.0 1.0 5 P61916 1 |
| Mapk and nfkb signaling pathways inhibited by yersinia yopj 0.5185185185185257 0.3190777971690623 0.749667519664716 1.0 1.0 3 O14920,O15111 2 |
| Proteasome degradation 0.3145615582752382 0.3154818378844423 0.7523958387929697 1.0 1.0 42 P28074,P49721,P28070,O00231,P46934,P20618,P01889,P10321,P28072 9 |
| Type i collagen synthesis in the context of osteogenesis imperfecta 0.3800267734381931 0.2850154765056513 0.7756322849411164 1.0 1.0 12 P13674,Q32P28,Q96AY3,O75718 4 |
| Dna replication 0.3214880678051738 0.2542190573342589 0.799326328509256 1.0 1.0 31 P41440,Q9Y619,P33993 3 |
| Nuclear receptors metapathway 0.2924275823726848 0.2538324192778358 0.7996250265316089 1.0 1.0 48 P09601,P23786,Q9HCL2 3 |
| Mitochondrial gene expression 0.4093972516280811 0.2470280708281103 0.8048864997711498 1.0 1.0 5 O00411 1 |
| Relationship between inflammation cox2 and egfr 0.4056478794883006 0.2359010831368365 0.8135094277472792 1.0 1.0 5 P31751,Q9H7Z7 2 |
| Purinergic signaling 0.4069115815691135 0.1924784923117819 0.8473674135703289 1.0 1.0 4 P63096,P04899,Q96RD7 3 |
| Id signaling pathway 0.5830740510267627 0.186055891973321 0.8524009309904246 1.0 1.0 2 P24941 1 |
| Insulin signaling in adipocytes diabetic condition 0.4034869240348668 0.1850407325004611 0.8531970872822296 1.0 1.0 4 P42345,P31751,O60343 3 |
| Insulin signaling in adipocytes normal condition 0.4034869240348668 0.1850407325004611 0.8531970872822296 1.0 1.0 4 P42345,P31751,O60343 3 |
| Liver x receptor pathway 0.5756067205973909 0.1745503748274793 0.8614329449566691 1.0 1.0 2 P49327 1 |
| Robo4 and vegf signaling pathways crosstalk 0.4431995020230336 0.1676512148898158 0.866857677715547 1.0 1.0 3 P12931,O94813 2 |
| Vitamin b12 disorders 0.4311736563718003 0.1497791492177698 0.8809388602818531 1.0 1.0 3 Q96EY8 1 |
| T cell receptor and costimulatory signaling 0.3521927342390942 0.1363068234639647 0.8915787298879265 1.0 1.0 7 P49841,P48729,Q08209 3 |
| Hedgehog signaling pathway wp47 0.5373366521468662 0.1252602900878885 0.9003174884417122 1.0 1.0 2 Q96ST3 1 |
| Fluoropyrimidine activity 0.3397262239235556 0.1144751018475242 0.9088611824816956 1.0 1.0 12 P00374 1 |
| Mammary gland development pathway pregnancy and lactation stage 3 of 4 0.3578324509498622 0.1125574628535122 0.9103814103875169 1.0 1.0 5 P06730,P61201,P06753,O15111 4 |
| Bile acids synthesis and enterohepatic circulation 0.5183571873055492 0.1065251128835201 0.9151657315660588 1.0 1.0 2 P51114 1 |
| Metastatic brain tumor 0.3899782135076249 0.1014970289388456 0.9191559159443956 1.0 1.0 3 P60953,Q00534 2 |
| Mrna protein and metabolite inducation pathway by cyclosporin a 0.507778469197272 0.0975961185758821 0.922253006721041 1.0 1.0 2 P08195 1 |
| Genes related to primary cilium development based on crispr 0.3313642715148842 0.0909049090926444 0.927568149454438 1.0 1.0 13 Q10713,O95684,A0AVF1 3 |
| Familial hyperlipidemia type 2 0.4912881144990754 0.0856753393828727 0.9317245063525128 1.0 1.0 2 Q5SW96 1 |
| Arachidonate epoxygenase epoxide hydrolase 0.4912881144990699 0.0856753393828691 0.9317245063525156 1.0 1.0 2 P20674 1 |
| Cellular proteostasis 0.3444409841170999 0.0846550026792796 0.9325356701507987 1.0 1.0 5 P61758,Q9UHV9,Q99471,Q9NQP4 4 |
| Sudden infant death syndrome sids susceptibility pathways 0.2960866268601932 0.0822793989605848 0.9344245361141004 1.0 1.0 26 P12235,P42892 2 |
| Complement system in neuronal development and plasticity 0.3325438582027314 0.0815687046971292 0.9349896883728956 1.0 1.0 11 Q5KU26 1 |
| Microglia pathogen phagocytosis pathway 0.3415317559153152 0.079531268561152 0.9366100616597356 1.0 1.0 4 O00459,O00443,P63000 3 |
| Sarscov2 b117 variant antagonises innate immune activation 0.4657747355320468 0.0715203776495174 0.942983607066484 1.0 1.0 2 Q7Z434 1 |
| Ppar signaling pathway 0.315432063281233 0.0601630649015853 0.9520257623422022 1.0 1.0 16 O15254,Q15067,P23786 3 |
| Oligodendrocyte specification and differentiation leading to myelin components for cns 0.4063472308649628 0.053771986719858 0.9571168285777664 1.0 1.0 2 Q99640 1 |
| Microrna network associated with chronic lymphocytic leukemia 0.38985687616677 0.0514253135036823 0.9589866141967168 1.0 1.0 2 Q07820 1 |
| Fatty acid transporters 0.3245094985985698 0.0487549934054145 0.961114549549046 1.0 1.0 5 Q9UKU0,O60488,O95573,P33121 4 |
| Cardiac progenitor differentiation 0.2958929682638374 0.0471068513198664 0.9624280668379196 1.0 1.0 2 P49841 1 |
| Endothelin pathways 0.3205446031557159 0.0436382515735744 0.965192760379792 1.0 1.0 8 P00403,P42892 2 |
| Primary focal segmental glomerulosclerosis fsgs 0.3030006647566472 0.0361761547102867 0.9711418993255712 1.0 1.0 18 Q14108 1 |
| Mirnas involvement in the immune response in sepsis 0.2960772104607697 0.0356058982826668 0.9715966051561284 1.0 1.0 4 Q15750,O14920,O15111 3 |
| Oxidative damage response 0.2885805613921766 0.0306961986739128 0.9755118227542848 1.0 1.0 4 O95429 1 |
| Transcription cofactors ski and skil protein partners 0.303643724696359 0.0183013111546406 0.985398481492356 1.0 1.0 5 Q13547,P21359,Q96ST3,P51608 4 |
| Regulation of sister chromatid separation at the metaphaseanaphase transition 0.3116914705206353 0.0170669946037741 0.9863831695665106 1.0 1.0 9 Q9UJX6 1 |
| G1 to s cell cycle control 0.2865915357546812 0.0116360610285898 0.9907159760634504 1.0 1.0 29 Q9Y619,Q14566,Q9UBD5,P51948,P33993 5 |
| Spinal cord injury 0.2889917475782213 0.0079049845431402 0.9936928005679118 1.0 1.0 20 P08670,Q9NQC3,P14174,Q08722,P60953 5 |
| Nucleotide excision repair 0.2844845578267632 0.0055167015513794 0.9955983313323362 1.0 1.0 27 P41440,Q16531,P54725,Q9NRF9 4 |
|
|
